Remove Clinical Trials Remove Drug Trials Remove FDA Approval Remove Licensing
article thumbnail

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

XTalks

Related: After 18 Years, FDA Approves Malaria Prevention Drug. It is the world’s first and only licensed malaria vaccine and also the first licensed for use against a human parasitic disease of any kind. Developing an efficacious vaccine against malaria has been a huge challenge.

article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials.

article thumbnail

LQTT secures $19M; Nanox acquires Zebra Medical Vision; Takeda leads IBD drugVisus raises $20M

Delveinsight

The two-year-old Canadian biotech will utilize series A to bring a lineup of SGK1 inhibitors through phase 1 clinical studies. LQTT has a portfolio of in-licensed compounds from Sanofi that prohibit serum/glucocorticoid-regulated kinase 1, or SGK1. Sage Partner and existing backers also participated.

Trials 97